{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:38:03Z","timestamp":1786736283834,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Cancer"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/ijc.ijc_622_17","type":"journal-article","created":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T03:07:08Z","timestamp":1560222428000},"page":"222","source":"Crossref","is-referenced-by-count":8,"title":["Gemcitabine with carboplatin for advanced intrahepatic cholangiocarcinoma: A study from North India Cancer Centre"],"prefix":"10.4103","volume":"55","author":[{"given":"VenkataPradeep K","family":"Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Talwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubhra","family":"Raina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varun","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PrasantaK","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavani","family":"Medisetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharma","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaturbhuj","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koundinya","family":"Desiraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DineshC","family":"Doval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-509X.250896-1","unstructured":"Ahlgren J. Neoplasms of the Hepatobiliary System. New York: McGraw-Hill; 1993."},{"key":"key-10.4103\/0019-509X.250896-2","doi-asserted-by":"crossref","unstructured":"Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise. Oncologist 2016;21:594-9.","DOI":"10.1634\/theoncologist.2015-0446"},{"key":"key-10.4103\/0019-509X.250896-3","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bjs.1800610205","article-title":"Cancer of the biliary system: A study of 445 cases","author":"Shani","year":"1974","journal-title":"Br J Surg"},{"key":"key-10.4103\/0019-509X.250896-4","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/oxfordjournals.annonc.a010676","article-title":"Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer","author":"Glimelius","year":"1996","journal-title":"Ann Oncol"},{"key":"key-10.4103\/0019-509X.250896-5","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.250896-6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eururo.2006.12.029","article-title":"Gemcitabine plus cisplatin versus gemcitabine plus carboplatin as first-line chemotherapy in advanced transitional cell carcinoma of the urothelium: Results of a randomized phase 2 trial","author":"Dogliotti","year":"2007","journal-title":"Eur Urol"},{"key":"key-10.4103\/0019-509X.250896-7","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1200\/JCO.2006.06.0913","article-title":"Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: An intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG","author":"Pfisterer","year":"2006","journal-title":"J Clin Oncol"},{"key":"key-10.4103\/0019-509X.250896-8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3816\/CBC.2008.n.051","article-title":"A phase II trial of gemcitabine\/carboplatin with or without trastuzumab in the first-line treatment of patients with metastatic breast cancer","author":"Yardley","year":"2008","journal-title":"Clin Breast Cancer"},{"key":"key-10.4103\/0019-509X.250896-9","first-page":"2191","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","author":"World","year":"2013","journal-title":"JAMA"},{"key":"key-10.4103\/0019-509X.250896-10","doi-asserted-by":"crossref","unstructured":"Ueno H, Okusaka T, Ikeda M, Takezako Y, Morizane C. Phase II study of S-1 in patients with advanced biliary tract cancer. Br J Cancer 2004;91:1769-74","DOI":"10.1038\/sj.bjc.6602208"},{"key":"key-10.4103\/0019-509X.250896-11","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/1097-0142(19840915)54:6<965::AID-CNCR2820540603>3.0.CO;2-X","article-title":"Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer","author":"Falkson","year":"1984","journal-title":"Cancer"},{"key":"key-10.4103\/0019-509X.250896-12","first-page":"126","article-title":"Gastrointestinal cancers in India: Treatment perspective","author":"Ghadyalpatil","year":"2016","journal-title":"South Asian J Cancer","ISSN":"https:\/\/id.crossref.org\/issn\/2278-330X","issn-type":"print"},{"key":"key-10.4103\/0019-509X.250896-13","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bjs.1800610205","article-title":"Cancer of the biliary system: A study of 445 cases","author":"Shani","year":"1974","journal-title":"Br J Surg"},{"key":"key-10.4103\/0019-509X.250896-14","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/sj.bjc.6603648","article-title":"Chemotherapy in advanced biliary tract carcinoma: A pooled analysis of clinical trials","author":"Eckel","year":"2007","journal-title":"Br J Cancer"},{"key":"key-10.4103\/0019-509X.250896-15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1477-2574.2010.00197.x","article-title":"Gemcitabine with carboplatin for advanced biliary tract cancers: A phase II single institution study","author":"Williams","year":"2010","journal-title":"HPB (Oxford)"},{"key":"key-10.4103\/0019-509X.250896-16","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"ABC-02 Trial Investigators.Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","author":"Valle","year":"2010","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-509X.250896-17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: A meta-analysis of two randomised trials","author":"Valle","year":"2014","journal-title":"Ann Oncol"}],"container-title":["Indian Journal of Cancer"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:39:52Z","timestamp":1786732792000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijc.IJC_622_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["250896"],"URL":"https:\/\/doi.org\/10.4103\/ijc.ijc_622_17","relation":{},"ISSN":["0019-509X"],"issn-type":[{"value":"0019-509X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}